APPLICATION
ANDA205257
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-22
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 200MG · TABLET, EXTENDED RELEASE · ORAL
TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 300MG · TABLET, EXTENDED RELEASE · ORAL
TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 100MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2026-06-18REMS · Supplement 16AP
2025-12-23Labeling · Supplement 14 · standardAP
2025-09-30Labeling · Supplement 12 · standardAP
2024-10-31REMS · Supplement 13AP
2023-12-15Labeling · Supplement 11 · standardAP
2021-09-10Labeling · Supplement 10 · standardAP
2021-03-04Labeling · Supplement 9 · standardAP
2019-10-11Labeling · Supplement 8 · standardAP
2018-09-21Labeling · Supplement 7 · standardAP
2018-09-18REMS · Supplement 6AP
2018-08-24Labeling · Supplement 5 · standardAP
2017-08-29Labeling · Supplement 4 · standardAP
2017-08-21Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.